228 related articles for article (PubMed ID: 35612286)
21. How Molecular Mobility, Physical State, and Drug Distribution Influence the Naproxen Release Profile from Different Mesoporous Silica Matrices.
d'Orey P; Cordeiro T; Lourenço MAO; Matos I; Danède F; Sotomayor JC; Fonseca IM; Ferreira P; Correia NT; Dionísio M
Mol Pharm; 2021 Mar; 18(3):898-914. PubMed ID: 33461296
[TBL] [Abstract][Full Text] [Related]
22. Improved solubility of lornoxicam by inclusion into SBA-15: Comparison of loading methods.
Dadej A; Woźniak-Braszak A; Bilski P; Piotrowska-Kempisty H; Józkowiak M; Pawełczyk A; Dadej D; Łażewska D; Jelińska A
Eur J Pharm Sci; 2022 Apr; 171():106133. PubMed ID: 35066153
[TBL] [Abstract][Full Text] [Related]
23. Nanoconfinement of a Pharmaceutical Cocrystal with Praziquantel in Mesoporous Silica: The Influence of the Solid Form on Dissolution Enhancement.
Salas-Zúñiga R; Mondragón-Vásquez K; Alcalá-Alcalá S; Lima E; Höpfl H; Herrera-Ruiz D; Morales-Rojas H
Mol Pharm; 2022 Feb; 19(2):414-431. PubMed ID: 34967632
[TBL] [Abstract][Full Text] [Related]
24. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.
Chen B; Wang Z; Quan G; Peng X; Pan X; Wang R; Xu Y; Li G; Wu C
Int J Nanomedicine; 2012; 7():199-209. PubMed ID: 22275835
[TBL] [Abstract][Full Text] [Related]
26. Inclusion of fenofibrate in a series of mesoporous silicas using microwave irradiation.
Waters LJ; Hussain T; Parkes G; Hanrahan JP; Tobin JM
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):936-41. PubMed ID: 23954510
[TBL] [Abstract][Full Text] [Related]
27. Use of SBA-15 for furosemide oral delivery enhancement.
Ambrogi V; Perioli L; Pagano C; Marmottini F; Ricci M; Sagnella A; Rossi C
Eur J Pharm Sci; 2012 May; 46(1-2):43-8. PubMed ID: 22365882
[TBL] [Abstract][Full Text] [Related]
28. Electrosprayed Polymeric Nanospheres for Enhanced Solubility, Dissolution Rate, Oral Bioavailability and Antihyperlipidemic Activity of Bezafibrate.
Sun R; Shen C; Shafique S; Mustapha O; Hussain T; Khan IU; Mehmood Y; Anwer K; Shahzad Y; Yousaf AM
Int J Nanomedicine; 2020; 15():705-715. PubMed ID: 32099359
[TBL] [Abstract][Full Text] [Related]
29. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936
[TBL] [Abstract][Full Text] [Related]
30. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica.
Yan HM; Sun E; Cui L; Jia XB; Jin X
J Pharm Pharmacol; 2015 Sep; 67(9):1207-14. PubMed ID: 25944009
[TBL] [Abstract][Full Text] [Related]
31. Production of a new platform based on fumed and mesoporous silica nanoparticles for enhanced solubility and oral bioavailability of raloxifene HCl.
Varshosaz J; Dayani L; Chegini SP; Minaiyan M
IET Nanobiotechnol; 2019 Jun; 13(4):392-399. PubMed ID: 31171744
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of mesoporous silica and its application as drug delivery system for glimepiride.
Muhana F; Al-Ani I; Al-Akayleh F; Marzouqa D; Khalili F; Al-Khatib H; Mutti H; Shalan N
Pharmazie; 2021 Jul; 76(7):300-307. PubMed ID: 34256891
[TBL] [Abstract][Full Text] [Related]
33. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.
Hong S; Shen S; Tan DC; Ng WK; Liu X; Chia LS; Irwan AW; Tan R; Nowak SA; Marsh K; Gokhale R
Drug Deliv; 2016; 23(1):316-27. PubMed ID: 24853963
[TBL] [Abstract][Full Text] [Related]
34. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
35. Impregnation of Fenofibrate on mesoporous silica using supercritical carbon dioxide.
Bouledjouidja A; Masmoudi Y; Van Speybroeck M; Schueller L; Badens E
Int J Pharm; 2016 Feb; 499(1-2):1-9. PubMed ID: 26732521
[TBL] [Abstract][Full Text] [Related]
36. A Comparative Loading and Release Study of Vancomycin from a Green Mesoporous Silica.
Dolete G; Purcăreanu B; Mihaiescu DE; Ficai D; Oprea OC; Bîrcă AC; Chircov C; Vasile BȘ; Vasilievici G; Ficai A; Andronescu E
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080354
[TBL] [Abstract][Full Text] [Related]
37. Development and evaluation of hollow mesoporous silica microspheres bearing on enhanced oral delivery of curcumin.
Gao Y; Ding S; Huang X; Fan Z; Sun J; Hai Y; Li K
Drug Dev Ind Pharm; 2019 Feb; 45(2):273-281. PubMed ID: 30346852
[TBL] [Abstract][Full Text] [Related]
38. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement.
Vadia N; Rajput S
Eur J Pharm Sci; 2012 Jan; 45(1-2):8-18. PubMed ID: 22067974
[TBL] [Abstract][Full Text] [Related]
39. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
Zhang Y; Zhi Z; Jiang T; Zhang J; Wang Z; Wang S
J Control Release; 2010 Aug; 145(3):257-63. PubMed ID: 20450945
[TBL] [Abstract][Full Text] [Related]
40. Imidazolium-based ionic liquid functionalized mesoporous silica nanoparticles as a promising nano-carrier: response surface strategy to investigate and optimize loading and release process for Lapatinib delivery.
Peyvand P; Vaezi Z; Sedghi M; Dalir N; Ma'mani L; Naderi-Manesh H
Pharm Dev Technol; 2020 Nov; 25(9):1150-1161. PubMed ID: 32746669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
